NEW PRICING RULES FOR LOW-COST PHARMACEUTICALS

Avellum Partners, Kyiv, Ukraine
Thu, Nov 27, 2014

On12 November 2014, the Cabinet of Ministers of Ukraine passed Resolution No. 639“On Amendments to Paragraph 1 of the Resolution of the Cabinet of Ministers ofUkraine No. 955 dated 17 October 2008” (“Resolution”) amending the pricingrules in the Ukrainian pharmaceutical market. Amended rules concernpharmaceutical products that cost less than UAH12 (“low-cost pharmaceuticals”)and are aimed at establishing equal treatment of Ukrainian and foreign low-costpharmaceuticals.

Undercurrently effective rules low-cost pharmaceuticals produced in Ukraine areexempt from price regulation (mark-up restriction). Under the new rules 25%mark-up restriction will apply to all low-cost pharmaceuticals (produced bothin Ukraine and abroad).

TheResolution will become effective on 1 January 2015. 

***

AvellumPartners

Tier1 within Mergers and Acquisitions and Banking and Finance: IFLR1000 2014 and2015

Band1 within Banking and Finance and Capital Markets: Chambers Europe 2014

TopTier Firm within Banking and Finance, Capital Markets, and Corporate/M&A:Legal500 2014 

Avellum Partners are the legal experts incorporate finance. We provide legal advice to our clients with respect to theirmost significant business transactions in arbitration, capital markets,competition, customs, finance, mergers and acquisitions, projects, energy andinfrastructure, real estate, restructurings, and tax. We specialize in mattersthat require special attention, extensive experience and industry expertise.Avellum Partners have one of the largest professional teams of lawyers on theUkrainian legal market specializing in corporate finance. The team consists ofhighly qualified attorneys trained on most sophisticated transactions.